Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study.
CONCLUSIONS: In-hospital heparin treatment was associated with lower mortality, particularly in severely ill COVID-19 patients and in those with strong coagulation activation. The results from randomised clinical trials are eagerly awaited to provide clear-cut recommendations.
PMID: 33412596 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Di Castelnuovo AF, Costanzo S, Iacoviello L Tags: Thromb Haemost Source Type: research
More News: Clinical Trials | COVID-19 | Hematology | Italy Health | Laboratory Medicine | SARS | Study | Thrombosis